268 related articles for article (PubMed ID: 12921219)
1. Neurotransmitter interactions in psychotropic drug action: beyond dopamine and serotonin.
Greenshaw AJ
J Psychiatry Neurosci; 2003 Jul; 28(4):247-50. PubMed ID: 12921219
[No Abstract] [Full Text] [Related]
2. [Old and new thought concepts on the biochemical principles of psychopharmcotherapy].
Wunderlich H; Wunderlich HP
Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():61-80. PubMed ID: 6130615
[No Abstract] [Full Text] [Related]
3. [The future of biological psychiatry].
Linnoila M
Duodecim; 1985; 101(17):1732-7. PubMed ID: 2865128
[No Abstract] [Full Text] [Related]
4. [Neurotransporters : new aspects of the mechanism of action of psychotropic drugs].
Lesch KP; Beckmann H
Nervenarzt; 1993 Jan; 64(1):75-9. PubMed ID: 8094894
[No Abstract] [Full Text] [Related]
5. Recent developments in neurobiology: Part II. Neurotransmitter receptors and psychopharmacology.
Hyman SE
Psychosomatics; 1988; 29(3):254-63. PubMed ID: 2900534
[No Abstract] [Full Text] [Related]
6. [Neurochemical strategy in the study of the mechanism of action of currently used antipsychotic drugs].
Raevskiĭ KS
Vestn Ross Akad Med Nauk; 1992; (7):21-5. PubMed ID: 1281703
[No Abstract] [Full Text] [Related]
7. Prolegomenon to the clinical prerequisite: psychopharmacology and the classification of mental disorders.
Ban TA
Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(5):527-80. PubMed ID: 2892227
[No Abstract] [Full Text] [Related]
8. [Psychopharmaceuticals as instruments for research].
Vinar O
Cesk Psychiatr; 1988 Feb; 84(1):28-35. PubMed ID: 2896551
[No Abstract] [Full Text] [Related]
9. Deconstructing psychiatric disorders, part 2: An emerging, neurobiologically based therapeutic strategy for the modern psychopharmacologist.
Stahl SM
J Clin Psychiatry; 2003 Oct; 64(10):1145-6. PubMed ID: 14658960
[No Abstract] [Full Text] [Related]
10. Psychoactive drug use in evolutionary perspective.
Nesse RM; Berridge KC
Science; 1997 Oct; 278(5335):63-6. PubMed ID: 9311928
[TBL] [Abstract][Full Text] [Related]
11. Why Monitor Molecules in Neuroscience?
Andrews AM
ACS Chem Neurosci; 2017 Feb; 8(2):211-212. PubMed ID: 28196419
[No Abstract] [Full Text] [Related]
12. The "highs and lows" of the human brain on dopaminergics: Evidence from neuropharmacology.
Martins D; Mehta MA; Prata D
Neurosci Biobehav Rev; 2017 Sep; 80():351-371. PubMed ID: 28624433
[TBL] [Abstract][Full Text] [Related]
13. Use of serotonergic agents in the clinical assessment of central serotonin function.
Murphy DL; Mueller EA; Garrick NA; Aulakh CS
J Clin Psychiatry; 1986 Apr; 47 Suppl():9-15. PubMed ID: 3514586
[TBL] [Abstract][Full Text] [Related]
14. The dopamine D3 receptor: From preclinical studies to the treatment of psychiatric disorders.
Drago F
Eur Neuropsychopharmacol; 2015 Sep; 25(9):1399-400. PubMed ID: 26278782
[No Abstract] [Full Text] [Related]
15. Stereopsychopharmacology: past, present and future.
Smith DF
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(3):327-50. PubMed ID: 6091180
[TBL] [Abstract][Full Text] [Related]
16. [Stimulant amino acids, glutamate receptors and pathology of the central nervous system].
Raevskiĭ KS
Patol Fiziol Eksp Ter; 1990; (1):3-9. PubMed ID: 1972271
[No Abstract] [Full Text] [Related]
17. Initiation and adaptation: a paradigm for understanding psychotropic drug action.
Hyman SE; Nestler EJ
Am J Psychiatry; 1996 Feb; 153(2):151-62. PubMed ID: 8561194
[TBL] [Abstract][Full Text] [Related]
18. The ABCs of psychopharmacology.
Keltner NL; Kelley FJ
Perspect Psychiatr Care; 2003; 39(4):169-73. PubMed ID: 14737823
[TBL] [Abstract][Full Text] [Related]
19. New psychoactive drugs.
Murray JB
Genet Soc Gen Psychol Monogr; 1985 Nov; 111(4):429-53. PubMed ID: 2873081
[TBL] [Abstract][Full Text] [Related]
20. Anatomic and molecular principles of psychopharmacology. A primer for psychiatrists.
Heckers S; Konradi C
Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):1-22. PubMed ID: 10674188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
